Pfizer sold $7.8B in COVID vaccines in 2Q, predicts more Delta-driven demand
NY Post
Pfizer sold a staggering $7.8 billion worth of coronavirus jabs during the second quarter — and predicted its profits will continue to explode as the Delta variant spurs fresh demand for booster shots.
The New York pharma giant — which said it is planning to submit a COVID booster shot for approval as soon as next week — expects to make a whopping $33.5 billion from selling 2.1 billion coronavirus vaccines this year, chief financial officer Frank D’Amelio told investors on Wednesday. That’s a nearly 30 percent increase from the company’s previous projections — and makes the two-dose vaccine, which was developed jointly with Germany’s BioNTech, among the most profitable drugs in history.More Related News